First Trust Advisors LP boosted its position in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 295.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 171,378 shares of the company's stock after acquiring an additional 128,056 shares during the quarter. First Trust Advisors LP owned 0.11% of Integral Ad Science worth $1,789,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently made changes to their positions in IAS. Barclays PLC increased its holdings in Integral Ad Science by 207.1% in the 3rd quarter. Barclays PLC now owns 127,733 shares of the company's stock worth $1,380,000 after acquiring an additional 86,133 shares in the last quarter. Franklin Resources Inc. raised its position in shares of Integral Ad Science by 12.9% during the 3rd quarter. Franklin Resources Inc. now owns 110,449 shares of the company's stock valued at $1,191,000 after buying an additional 12,647 shares in the last quarter. JPMorgan Chase & Co. raised its position in Integral Ad Science by 47.6% during the third quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company's stock valued at $7,756,000 after purchasing an additional 231,271 shares during the period. Jennison Associates LLC lifted its position in Integral Ad Science by 3.3% in the fourth quarter. Jennison Associates LLC now owns 63,538 shares of the company's stock worth $663,000 after buying an additional 2,046 shares during the last quarter. Finally, Stoneridge Investment Partners LLC lifted its holdings in shares of Integral Ad Science by 139.7% in the 4th quarter. Stoneridge Investment Partners LLC now owns 27,808 shares of the company's stock worth $290,000 after acquiring an additional 16,208 shares during the last quarter. Hedge funds and other institutional investors own 95.78% of the company's stock.
Integral Ad Science Stock Performance
IAS traded down $0.07 on Friday, reaching $7.72. The stock had a trading volume of 1,389,653 shares, compared to its average volume of 1,016,187. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07. Integral Ad Science Holding Corp. has a 12-month low of $6.26 and a 12-month high of $13.62. The business's 50-day moving average price is $7.86 and its two-hundred day moving average price is $9.73. The company has a market cap of $1.26 billion, a P/E ratio of 38.60, a price-to-earnings-growth ratio of 1.06 and a beta of 1.55.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its quarterly earnings results on Friday, February 28th. The company reported $0.09 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.03). The company had revenue of $153.00 million during the quarter, compared to analysts' expectations of $148.83 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. Integral Ad Science's revenue was up 13.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.06 EPS. Sell-side analysts forecast that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.
Analyst Ratings Changes
Several analysts have recently weighed in on the company. Benchmark reiterated a "hold" rating on shares of Integral Ad Science in a research report on Friday, February 28th. Scotiabank assumed coverage on shares of Integral Ad Science in a research report on Friday, February 28th. They set a "sector perform" rating and a $12.00 price target for the company. Morgan Stanley lowered their price objective on Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Raymond James dropped their target price on shares of Integral Ad Science from $16.00 to $11.00 and set an "outperform" rating on the stock in a research report on Monday, May 5th. Finally, Robert W. Baird reissued a "neutral" rating and issued a $9.00 price objective (down from $16.00) on shares of Integral Ad Science in a report on Friday, March 28th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $13.15.
Read Our Latest Research Report on Integral Ad Science
Insider Transactions at Integral Ad Science
In other news, CEO Lisa Utzschneider sold 8,547 shares of the business's stock in a transaction that occurred on Monday, April 7th. The stock was sold at an average price of $6.85, for a total transaction of $58,546.95. Following the transaction, the chief executive officer now directly owns 341,271 shares in the company, valued at $2,337,706.35. The trade was a 2.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have sold 86,222 shares of company stock valued at $636,252 over the last ninety days. Insiders own 2.00% of the company's stock.
Integral Ad Science Company Profile
(
Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Recommended Stories

Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.